Stay updated on Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:53:19.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has updated its date references, replacing older dates with new ones, and has changed the postal code for Gdańsk, Poland.
    Difference
    0.3%
    Check dated 2025-04-23T08:21:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page has been updated to include new genetic mutation information related to breast cancer and has revised the version number to v2.15.0. Notably, extensive details about a clinical study, including inclusion and exclusion criteria, have been removed.
    Difference
    8%
    Check dated 2025-04-16T01:45:03.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 20, 2025.
    Difference
    0.3%
    Check dated 2025-04-08T20:21:30.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of January 20, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T14:57:21.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T18:34:56.000Z thumbnail image

Stay in the know with updates to Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.